Esoblok 20mg Tablet contains isotretinoin, a potent retinoid primarily indicated for the treatment of severe recalcitrant nodular acne that has not responded to conventional therapies, including systemic antibiotics. Isotretinoin acts by reducing sebaceous gland size and sebum production, inhibiting the growth of acne-causing bacteria, and exerting anti-inflammatory effects, thereby addressing multiple pathogenic factors of acne vulgaris. Each tablet delivers 20mg of isotretinoin, administered orally, with dosage tailored according to patient weight, severity of condition, and clinical response. Due to its teratogenic potential, Esoblok is contraindicated in pregnancy, and strict contraceptive measures must be observed during treatment and for a specified period thereafter. Common adverse effects include dry skin, cheilitis, conjunctivitis, and transient elevations in liver enzymes and lipid profiles, necessitating regular monitoring. Patients should avoid excessive sun exposure and use moisturizers to alleviate mucocutaneous symptoms. Esoblok should be prescribed and supervised by a dermatologist or healthcare professional experienced in isotretinoin therapy to ensure safe and effective use. It is essential to follow all recommended guidelines and laboratory evaluations to minimize risks and optimize therapeutic outcomes.